시장보고서

상품코드

1625476

지혈제 및 조직 실링제 시장 규모, 점유율, 동향, 산업 분석 보고서 : 제품별, 재료별, 용도별, 최종사용자별, 지역별 - 시장 예측(2025-2034년)

Hemostasis and Tissue Sealing Agents Market Size, Share, Trends, Industry Analysis Report: By Product, Material, Application, End User, and Region - Market Forecast, 2025-2034

발행일: 2024년 12월 | 리서치사:

Polaris Market Research | 페이지 정보: 영문 118 Pages | 배송안내 : 1-2일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

Polaris Market Research의 최신 조사에 따르면, 세계 지혈제 및 조직 실링제 시장 규모는 2034년까지 213억 8,000만 달러에 달할 것으로 예상됩니다. 이 보고서는 현재 시장 역학에 대한 자세한 인사이트와 향후 시장 성장에 대한 분석을 제공합니다.

지혈제 및 조직 실링제 시장은 특히 만성질환 및 외상 관련 수술 건수 증가 등의 요인으로 인해 크게 성장하고 있습니다. 주요 촉진요인으로는 최소침습 수술의 발전, 보다 안전하고 효율적인 상처 봉합 솔루션에 대한 수요 증가, 복잡한 수술에서 더 나은 지혈 제어에 대한 필요성 등이 있습니다.

아시아태평양 및 라틴아메리카 등 개발도상국에서는 헬스케어 인프라가 빠르게 확장되고 있으며, 이에 따라 비즈니스 기회가 창출되고 있습니다. 바이오 기반 및 합성 소재로의 전환, 복합 제품 통합, 생체흡수성 실란트 개발 등의 트렌드가 시장을 형성하고 있습니다. 또한, 제품 효능 및 전달 시스템의 지속적인 기술 혁신, 전략적 파트너십 및 규제 발전과 함께 이 분야의 전체 시장 성장과 경쟁에 기여하고 있습니다.

지혈제 및 조직 실링제 시장 보고서 하이라이트

제품별로는 수술 시 출혈 억제에 널리 사용되는 국소 지혈제가 가장 큰 시장 점유율을 차지하고 있습니다. 접착제 및 조직 밀봉제 분야는 최소침습 수술에서 첨단 상처 봉합 솔루션에 대한 수요 증가로 인해 가장 높은 성장세를 보이고 있습니다.

재료별로는 키토산 기반이 천연 생체적합성과 출혈 억제 효과로 인해 지혈제 및 조직 실링제 시장 점유율을 독식하고 있습니다. 미네랄 기반 부문은 특히 응급 의료 및 외상 치료에서 심한 출혈을 효과적으로 제어할 수 있다는 점에서 가장 빠른 속도로 성장하고 있습니다.

용도별로는 효과적인 지혈제를 필요로 하는 시술의 범위가 넓은 일반외과 분야가 가장 큰 시장 점유율을 차지하고 있습니다. 최소침습 수술 분야는 복강경 및 로봇 보조술의 발전에 힘입어 가장 빠르게 성장하는 분야입니다.

최종사용자별로는 지혈제 및 조직 실링제가 필요한 대부분의 수술이 병원에서 이루어지기 때문에 병원 부문이 지혈제 및 조직 실링제 시장 매출에서 가장 큰 점유율을 차지하고 있습니다. 외래 수술 센터 시장은 외래 환자 및 당일 퇴원 수술의 증가로 인해 빠르게 성장하고 있습니다.

북미는 높은 의료 인프라와 높은 수술 건수를 바탕으로 시장을 독점하고 있습니다. 아시아태평양은 헬스케어 투자 증가, 의료관광, 수술 증가로 인해 가장 빠르게 성장하는 지역입니다.

시장 현황
지혈제 및 조직 실링제 시장 역학
- 성장 촉진요인과 기회
  - 바이오 기반 및 합성 재료 수요 증가
  - 최소침습 수술 기술 채용 증가
  - 복합 제품의 통합
- 성장 억제요인과 과제
  - 두통과 호흡 곤란
PESTEL 분석
지혈제 및 조직 실링제 시장 동향
밸류체인 분석
COVID-19의 영향 분석

제5장 세계의 지혈제 및 조직 실링제 시장 : 제품별

주요 조사 결과
소개
국소 지혈제
접착제 및 조직 실란트

제6장 세계의 지혈제 및 조직 실링제 시장 : 재료별

주요 조사 결과
소개
키토산 기반
미네랄 기반

제7장 세계의 지혈제 및 조직 실링제 시장 : 용도별

주요 조사 결과
소개
중증 외상
일반외과
최소침습 수술
부인과
기타

제8장 세계의 지혈제 및 조직 실링제 시장 : 최종사용자별

주요 조사 결과
소개
병원
외래 수술 센터
조사기관

제9장 세계의 지혈제 및 조직 실링제 시장 : 지역별

주요 조사 결과
소개
- 지혈제 및 조직 실링제 시장 평가 : 지역, 2020-2034년
북미
- 북미 : 제품별, 2020-2034년
- 북미 : 재료별, 2020-2034년
- 북미 : 용도별, 2020-2034년
- 북미 : 최종사용자별, 2020-2034년
- 미국
- 캐나다
유럽
- 유럽 : 제품별, 2020-2034년
- 유럽 : 재료별, 2020-2034년
- 유럽 : 용도별, 2020-2034년
- 유럽 : 최종사용자별, 2020-2034년
- 영국
- 프랑스
- 독일
- 이탈리아
- 스페인
- 네덜란드
- 러시아
- 기타 유럽
아시아태평양
- 아시아태평양 : 제품별, 2020-2034년
- 아시아태평양 : 재료별, 2020-2034년
- 아시아태평양 : 용도별, 2020-2034년
- 아시아태평양 : 최종사용자별, 2020-2034년
- 중국
- 인도
- 말레이시아
- 일본
- 인도네시아
- 한국
- 호주
- 기타 아시아태평양
중동 및 아프리카
- 중동 및 아프리카 : 제품별, 2020-2034년
- 중동 및 아프리카 : 재료별, 2020-2034년
- 중동 및 아프리카 : 용도별, 2020-2034년
- 중동 및 아프리카 : 최종사용자별, 2020-2034년
- 사우디아라비아
- 아랍에미리트
- 이스라엘
- 남아프리카공화국
- 기타 중동 및 아프리카
라틴아메리카
- 라틴아메리카 : 제품별, 2020-2034년
- 라틴아메리카 : 재료별, 2020-2034년
- 라틴아메리카 : 용도별, 2020-2034년
- 라틴아메리카 : 최종사용자별, 2020-2034년
- 멕시코
- 브라질
- 아르헨티나
- 기타 라틴아메리카

제10장 경쟁 구도

확대와 인수 분석
- 확대
- 인수
제휴/협업/합의/공개

제11장 기업 개요

Baxter International
Ethicon(a Subsidiary of Johnson & Johnson)
B. Braun
Integra LifeSciences
Medtronic
CryoLife
CSL Behring
Stryker Corporation
Pfizer
Cohera Medical
Advanced Medical Solutions Group
Haemacure Corporation
Mallinckrodt Pharmaceuticals
Arch Therapeutics

ksm 25.02.06

The global hemostasis and tissue sealing agents market size is expected to reach USD 21.38 billion by 2034, according to a new study by Polaris Market Research. The report "Hemostasis and Tissue Sealing Agents Market Size, Share, Trends, Industry Analysis Report: By Product (Topical Hemostat and Adhesive & Tissue Sealant), Material, Application, End User, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The hemostasis and tissue sealing agents market is experiencing significant growth, driven by factors such as the increasing volume of surgical procedures, particularly those related to chronic diseases and trauma. Key drivers include advancements in minimally invasive surgery, rising demand for safer and more efficient wound closure solutions, and the need for improved hemostatic control in complex surgeries.

Opportunities are emerging in developing regions such as Asia Pacific and Latin America, where healthcare infrastructure is expanding rapidly. Trends such as the shift toward bio-based and synthetic materials, the integration of combination products, and the development of bioresorbable sealants are shaping the market. Additionally, ongoing innovations in product efficacy and delivery systems, along with strategic partnerships and regulatory advancements, contribute to the overall market growth and competitiveness in the sector.

Hemostasis and Tissue Sealing Agents Market Report Highlights

Based on product, the topical hemostat segment holds the largest market share, driven by its widespread use in controlling bleeding during surgeries. The adhesive & tissue sealant segment is registering the highest growth due to increasing demand for advanced wound closure solutions in minimally invasive procedures.

In terms of material, the chitosan-based segment dominates the hemostasis and tissue sealing agents market share due to its natural biocompatibility and effectiveness in controlling bleeding. The mineral-based segment is growing at the fastest rate, particularly in emergency and trauma care, due to its efficiency in severe bleeding control.

The general surgery segment, by application, holds the largest market share, with a broad range of procedures requiring effective hemostatic agents. The minimally invasive surgery segment is the fastest-growing application, driven by advancements in laparoscopic and robotic-assisted techniques.

The hospitals segment, by end user, holds the largest share of the hemostasis and tissue sealing agents market revenue, as they conduct the majority of surgeries requiring hemostatic and tissue sealing agents. The ambulatory surgical centers segment is growing rapidly due to the rise in outpatient and same-day discharge procedures.

North America dominates the market, supported by its advanced healthcare infrastructure and high surgical volumes. Asia Pacific is the fastest-growing region, driven by increasing healthcare investments, medical tourism, and rising surgical procedures.

Polaris Market Research has segmented the hemostasis and tissue sealing agents market report on the basis of product, material, application, end user, and region:

By Product Outlook (Revenue - USD Billion, 2020-2034)

Topical Hemostat
Adhesive & Tissue Sealant

By Material Outlook (Revenue - USD Billion, 2020-2034)

Chitosan-Based
Mineral-Based

By Application Outlook (Revenue - USD Billion, 2020-2034)

Trauma
General Surgery
Minimally Invasive Surgery
Gynecology
Others

By End User Outlook (Revenue - USD Billion, 2020-2034)

Hospitals
Ambulatory Surgical Centers
Research Institutes

By Regional Outlook (Revenue - USD Billion, 2020-2034)

North America
US
Canada
Europe
Germany
France
UK
Italy
Spain
Netherlands
Russia
Rest of Europe
Asia Pacific
China
Japan
India
Malaysia
South Korea
Indonesia
Australia
Vietnam
Rest of Asia Pacific
Middle East & Africa
Saudi Arabia
UAE
Israel
South Africa
Rest of Middle East & Africa
Latin America
Mexico
Brazil
Argentina
Rest of Latin America

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Source
- 3.2.1. Primary Source
- 3.2.2. Secondary Source

4. Global Hemostasis and Tissue Sealing Agents Market Insights

4.1. Hemostasis and Tissue Sealing Agents Market - Market Snapshot
4.2. Hemostasis and Tissue Sealing Agents Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Increasing Demand for Bio-Based and Synthetic Materials
  - 4.2.1.2. Rising Adoption of Minimally Invasive Surgical Techniques
  - 4.2.1.3. Integration of Combination Products
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. Headache and difficulty in breathing
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Hemostasis and Tissue Sealing Agents Market Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis

5. Global Hemostasis and Tissue Sealing Agents Market, by Product

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Hemostasis and Tissue Sealing Agents Market, by Product, 2020-2034 (USD Billion)
5.3. Topical Hemostat
- 5.3.1. Global Hemostasis and Tissue Sealing Agents Market, by Topical Hemostat, by Region, 2020-2034 (USD Billion)
5.4. Adhesive & Tissue Sealant
- 5.4.1. Global Hemostasis and Tissue Sealing Agents Market, by Adhesive & Tissue Sealant, by Region, 2020-2034 (USD Billion)

6. Global Hemostasis and Tissue Sealing Agents Market, by Material

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Hemostasis and Tissue Sealing Agents Market, by Material, 2020-2034 (USD Billion)
6.3. Chitosan-Based
- 6.3.1. Global Hemostasis and Tissue Sealing Agents Market, by Chitosan-Based, by Region, 2020-2034 (USD Billion)
6.4. Mineral-Based
- 6.4.1. Global Hemostasis and Tissue Sealing Agents Market, by Mineral-Based, by Region, 2020-2034 (USD Billion)

7. Global Hemostasis and Tissue Sealing Agents Market, by Application

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global Hemostasis and Tissue Sealing Agents Market, by Application, 2020-2034 (USD Billion)
7.3. Trauma
- 7.3.1. Global Hemostasis and Tissue Sealing Agents Market, Trauma, by Region, 2020-2034 (USD Billion)
7.4. General Surgery
- 7.4.1. Global Hemostasis and Tissue Sealing Agents Market, by General Surgery, by Region, 2020-2034 (USD Billion)
7.5. Minimally Invasive Surgery
- 7.5.1. Global Hemostasis and Tissue Sealing Agents Market, by Minimally Invasive Surgery, by Region, 2020-2034 (USD Billion)
7.6. Gynecology
- 7.6.1. Global Hemostasis and Tissue Sealing Agents Market, by Gynecology, by Region, 2020-2034 (USD Billion)
7.7. Others
- 7.7.1. Global Hemostasis and Tissue Sealing Agents Market, by Others, by Region, 2020-2034 (USD Billion)

8. Global Hemostasis and Tissue Sealing Agents Market, by End User

8.1. Key Findings
8.2. Introduction
- 8.2.1. Global Hemostasis and Tissue Sealing Agents Market, by End User, 2020-2034 (USD Billion)
8.3. Hospitals
- 8.3.1. Global Hemostasis and Tissue Sealing Agents Market, by Hospitals, by Region, 2020-2034 (USD Billion)
8.4. Ambulatory Surgical Centers
- 8.4.1. Global Hemostasis and Tissue Sealing Agents Market, by Ambulatory Surgical Centers, by Region, 2020-2034 (USD Billion)
8.5. Research Institutes
- 8.5.1. Global Hemostasis and Tissue Sealing Agents Market, by Research Institutes, by Region, 2020-2034 (USD Billion)

9. Global Hemostasis and Tissue Sealing Agents Market, by Geography

9.1. Key Findings
9.2. Introduction
- 9.2.1. Hemostasis and Tissue Sealing Agents Market Assessment, By Geography, 2020-2034 (USD Billion)
9.3. Hemostasis and Tissue Sealing Agents Market - North America
- 9.3.1. North America: Hemostasis and Tissue Sealing Agents Market, by Product, 2020-2034 (USD Billion)
- 9.3.2. North America: Hemostasis and Tissue Sealing Agents Market, by Material, 2020-2034 (USD Billion)
- 9.3.3. North America: Hemostasis and Tissue Sealing Agents Market, by Application, 2020-2034 (USD Billion)
- 9.3.4. North America: Hemostasis and Tissue Sealing Agents Market, by End User, 2020-2034 (USD Billion)
- 9.3.5. Hemostasis and Tissue Sealing Agents Market - US
  - 9.3.5.1. US: Hemostasis and Tissue Sealing Agents Market, by Product, 2020-2034 (USD Billion)
  - 9.3.5.2. US: Hemostasis and Tissue Sealing Agents Market, by Material, 2020-2034 (USD Billion)
  - 9.3.5.3. US: Hemostasis and Tissue Sealing Agents Market, by Application, 2020-2034 (USD Billion)
  - 9.3.5.4. US: Hemostasis and Tissue Sealing Agents Market, by End User, 2020-2034 (USD Billion)
- 9.3.6. Hemostasis and Tissue Sealing Agents Market - Canada
  - 9.3.6.1. Canada: Hemostasis and Tissue Sealing Agents Market, by Product, 2020-2034 (USD Billion)
  - 9.3.6.2. Canada: Hemostasis and Tissue Sealing Agents Market, by Material, 2020-2034 (USD Billion)
  - 9.3.6.3. Canada: Hemostasis and Tissue Sealing Agents Market, by Application, 2020-2034 (USD Billion)
  - 9.3.6.4. Canada: Hemostasis and Tissue Sealing Agents Market, by End User, 2020-2034 (USD Billion)
9.4. Hemostasis and Tissue Sealing Agents Market - Europe
- 9.4.1. Europe: Hemostasis and Tissue Sealing Agents Market, by Product, 2020-2034 (USD Billion)
- 9.4.2. Europe: Hemostasis and Tissue Sealing Agents Market, by Material, 2020-2034 (USD Billion)
- 9.4.3. Europe: Hemostasis and Tissue Sealing Agents Market, by Application, 2020-2034 (USD Billion)
- 9.4.4. Europe: Hemostasis and Tissue Sealing Agents Market, by End User, 2020-2034 (USD Billion)
- 9.4.5. Hemostasis and Tissue Sealing Agents Market - UK
  - 9.4.5.1. UK: Hemostasis and Tissue Sealing Agents Market, by Product, 2020-2034 (USD Billion)
  - 9.4.5.2. UK: Hemostasis and Tissue Sealing Agents Market, by Material, 2020-2034 (USD Billion)
  - 9.4.5.3. UK: Hemostasis and Tissue Sealing Agents Market, by Application, 2020-2034 (USD Billion)
  - 9.4.5.4. UK: Hemostasis and Tissue Sealing Agents Market, by End User, 2020-2034 (USD Billion)
- 9.4.6. Hemostasis and Tissue Sealing Agents Market - France
  - 9.4.6.1. France: Hemostasis and Tissue Sealing Agents Market, by Product, 2020-2034 (USD Billion)
  - 9.4.6.2. France: Hemostasis and Tissue Sealing Agents Market, by Material, 2020-2034 (USD Billion)
  - 9.4.6.3. France: Hemostasis and Tissue Sealing Agents Market, by Application, 2020-2034 (USD Billion)
  - 9.4.6.4. France: Hemostasis and Tissue Sealing Agents Market, by End User, 2020-2034 (USD Billion)
- 9.4.7. Hemostasis and Tissue Sealing Agents Market - Germany
  - 9.4.7.1. Germany: Hemostasis and Tissue Sealing Agents Market, by Product, 2020-2034 (USD Billion)
  - 9.4.7.2. Germany: Hemostasis and Tissue Sealing Agents Market, by Material, 2020-2034 (USD Billion)
  - 9.4.7.3. Germany: Hemostasis and Tissue Sealing Agents Market, by Application, 2020-2034 (USD Billion)
  - 9.4.7.4. Germany: Hemostasis and Tissue Sealing Agents Market, by End User, 2020-2034 (USD Billion)
- 9.4.8. Hemostasis and Tissue Sealing Agents Market - Italy
  - 9.4.8.1. Italy: Hemostasis and Tissue Sealing Agents Market, by Product, 2020-2034 (USD Billion)
  - 9.4.8.2. Italy: Hemostasis and Tissue Sealing Agents Market, by Material, 2020-2034 (USD Billion)
  - 9.4.8.3. Italy: Hemostasis and Tissue Sealing Agents Market, by Application, 2020-2034 (USD Billion)
  - 9.4.8.4. Italy: Hemostasis and Tissue Sealing Agents Market, by End User, 2020-2034 (USD Billion)
- 9.4.9. Hemostasis and Tissue Sealing Agents Market - Spain
  - 9.4.9.1. Spain: Hemostasis and Tissue Sealing Agents Market, by Product, 2020-2034 (USD Billion)
  - 9.4.9.2. Spain: Hemostasis and Tissue Sealing Agents Market, by Material, 2020-2034 (USD Billion)
  - 9.4.9.3. Spain: Hemostasis and Tissue Sealing Agents Market, by Application, 2020-2034 (USD Billion)
  - 9.4.9.4. Spain: Hemostasis and Tissue Sealing Agents Market, by End User, 2020-2034 (USD Billion)
- 9.4.10. Hemostasis and Tissue Sealing Agents Market - Netherlands
  - 9.4.10.1. Netherlands: Hemostasis and Tissue Sealing Agents Market, by Product, 2020-2034 (USD Billion)
  - 9.4.10.2. Netherlands: Hemostasis and Tissue Sealing Agents Market, by Material, 2020-2034 (USD Billion)
  - 9.4.10.3. Netherlands: Hemostasis and Tissue Sealing Agents Market, by Application, 2020-2034 (USD Billion)
  - 9.4.10.4. Netherlands: Hemostasis and Tissue Sealing Agents Market, by End User, 2020-2034 (USD Billion)
- 9.4.11. Hemostasis and Tissue Sealing Agents Market - Russia
  - 9.4.11.1. Russia: Hemostasis and Tissue Sealing Agents Market, by Product, 2020-2034 (USD Billion)
  - 9.4.11.2. Russia: Hemostasis and Tissue Sealing Agents Market, by Material, 2020-2034 (USD Billion)
  - 9.4.11.3. Russia: Hemostasis and Tissue Sealing Agents Market, by Application, 2020-2034 (USD Billion)
  - 9.4.11.4. Russia: Hemostasis and Tissue Sealing Agents Market, by End User, 2020-2034 (USD Billion)
- 9.4.12. Hemostasis and Tissue Sealing Agents Market - Rest of Europe
  - 9.4.12.1. Rest of Europe: Hemostasis and Tissue Sealing Agents Market, by Product, 2020-2034 (USD Billion)
  - 9.4.12.2. Rest of Europe: Hemostasis and Tissue Sealing Agents Market, by Material, 2020-2034 (USD Billion)
  - 9.4.12.3. Rest of Europe: Hemostasis and Tissue Sealing Agents Market, by Application, 2020-2034 (USD Billion)
  - 9.4.12.4. Rest of Europe: Hemostasis and Tissue Sealing Agents Market, by End User, 2020-2034 (USD Billion)
9.5. Hemostasis and Tissue Sealing Agents Market - Asia Pacific
- 9.5.1. Asia Pacific: Hemostasis and Tissue Sealing Agents Market, by Product, 2020-2034 (USD Billion)
- 9.5.2. Asia Pacific: Hemostasis and Tissue Sealing Agents Market, by Material, 2020-2034 (USD Billion)
- 9.5.3. Asia Pacific: Hemostasis and Tissue Sealing Agents Market, by Application, 2020-2034 (USD Billion)
- 9.5.4. Asia Pacific: Hemostasis and Tissue Sealing Agents Market, by End User, 2020-2034 (USD Billion)
- 9.5.5. Hemostasis and Tissue Sealing Agents Market - China
  - 9.5.5.1. China: Hemostasis and Tissue Sealing Agents Market, by Product, 2020-2034 (USD Billion)
  - 9.5.5.2. China: Hemostasis and Tissue Sealing Agents Market, by Material, 2020-2034 (USD Billion)
  - 9.5.5.3. China: Hemostasis and Tissue Sealing Agents Market, by Application, 2020-2034 (USD Billion)
  - 9.5.5.4. China: Hemostasis and Tissue Sealing Agents Market, by End User, 2020-2034 (USD Billion)
- 9.5.6. Hemostasis and Tissue Sealing Agents Market - India
  - 9.5.6.1. India: Hemostasis and Tissue Sealing Agents Market, by Product, 2020-2034 (USD Billion)
  - 9.5.6.2. India: Hemostasis and Tissue Sealing Agents Market, by Material, 2020-2034 (USD Billion)
  - 9.5.6.3. India: Hemostasis and Tissue Sealing Agents Market, by Application, 2020-2034 (USD Billion)
  - 9.5.6.4. India: Hemostasis and Tissue Sealing Agents Market, by End User, 2020-2034 (USD Billion)
- 9.5.7. Hemostasis and Tissue Sealing Agents Market - Malaysia
  - 9.5.7.1. Malaysia: Hemostasis and Tissue Sealing Agents Market, by Product, 2020-2034 (USD Billion)
  - 9.5.7.2. Malaysia: Hemostasis and Tissue Sealing Agents Market, by Material, 2020-2034 (USD Billion)
  - 9.5.7.3. Malaysia: Hemostasis and Tissue Sealing Agents Market, by Application, 2020-2034 (USD Billion)
  - 9.5.7.4. Malaysia: Hemostasis and Tissue Sealing Agents Market, by End User, 2020-2034 (USD Billion)
- 9.5.8. Hemostasis and Tissue Sealing Agents Market - Japan
  - 9.5.8.1. Japan: Hemostasis and Tissue Sealing Agents Market, by Product, 2020-2034 (USD Billion)
  - 9.5.8.2. Japan: Hemostasis and Tissue Sealing Agents Market, by Material, 2020-2034 (USD Billion)
  - 9.5.8.3. Japan: Hemostasis and Tissue Sealing Agents Market, by Application, 2020-2034 (USD Billion)
  - 9.5.8.4. Japan: Hemostasis and Tissue Sealing Agents Market, by End User, 2020-2034 (USD Billion)
- 9.5.9. Hemostasis and Tissue Sealing Agents Market - Indonesia
  - 9.5.9.1. Indonesia: Hemostasis and Tissue Sealing Agents Market, by Product, 2020-2034 (USD Billion)
  - 9.5.9.2. Indonesia: Hemostasis and Tissue Sealing Agents Market, by Material, 2020-2034 (USD Billion)
  - 9.5.9.3. Indonesia: Hemostasis and Tissue Sealing Agents Market, by Application, 2020-2034 (USD Billion)
  - 9.5.9.4. Indonesia: Hemostasis and Tissue Sealing Agents Market, by End User, 2020-2034 (USD Billion)
- 9.5.10. Hemostasis and Tissue Sealing Agents Market - South Korea
  - 9.5.10.1. South Korea: Hemostasis and Tissue Sealing Agents Market, by Product, 2020-2034 (USD Billion)
  - 9.5.10.2. South Korea: Hemostasis and Tissue Sealing Agents Market, by Material, 2020-2034 (USD Billion)
  - 9.5.10.3. South Korea: Hemostasis and Tissue Sealing Agents Market, by Application, 2020-2034 (USD Billion)
  - 9.5.10.4. South Korea: Hemostasis and Tissue Sealing Agents Market, by End User, 2020-2034 (USD Billion)
- 9.5.11. Hemostasis and Tissue Sealing Agents Market - Australia
  - 9.5.11.1. Australia: Hemostasis and Tissue Sealing Agents Market, by Product, 2020-2034 (USD Billion)
  - 9.5.11.2. Australia: Hemostasis and Tissue Sealing Agents Market, by Material, 2020-2034 (USD Billion)
  - 9.5.11.3. Australia: Hemostasis and Tissue Sealing Agents Market, by Application, 2020-2034 (USD Billion)
  - 9.5.11.4. Australia: Hemostasis and Tissue Sealing Agents Market, by End User, 2020-2034 (USD Billion)
- 9.5.12. Hemostasis and Tissue Sealing Agents Market - Rest of Asia Pacific
  - 9.5.12.1. Rest of Asia Pacific: Hemostasis and Tissue Sealing Agents Market, by Product, 2020-2034 (USD Billion)
  - 9.5.12.2. Rest of Asia Pacific: Hemostasis and Tissue Sealing Agents Market, by Material, 2020-2034 (USD Billion)
  - 9.5.12.3. Rest of Asia Pacific: Hemostasis and Tissue Sealing Agents Market, by Application, 2020-2034 (USD Billion)
  - 9.5.12.4. Rest of Asia Pacific: Hemostasis and Tissue Sealing Agents Market, by End User, 2020-2034 (USD Billion)
9.6. Hemostasis and Tissue Sealing Agents Market - Middle East & Africa
- 9.6.1. Middle East & Africa: Hemostasis and Tissue Sealing Agents Market, by Product, 2020-2034 (USD Billion)
- 9.6.2. Middle East & Africa: Hemostasis and Tissue Sealing Agents Market, by Material, 2020-2034 (USD Billion)
- 9.6.3. Middle East & Africa: Hemostasis and Tissue Sealing Agents Market, by Application, 2020-2034 (USD Billion)
- 9.6.4. Middle East & Africa: Hemostasis and Tissue Sealing Agents Market, by End User, 2020-2034 (USD Billion)
- 9.6.5. Hemostasis and Tissue Sealing Agents Market - Saudi Arabia
  - 9.6.5.1. Saudi Arabia: Hemostasis and Tissue Sealing Agents Market, by Product, 2020-2034 (USD Billion)
  - 9.6.5.2. Saudi Arabia: Hemostasis and Tissue Sealing Agents Market, by Material, 2020-2034 (USD Billion)
  - 9.6.5.3. Saudi Arabia: Hemostasis and Tissue Sealing Agents Market, by Application, 2020-2034 (USD Billion)
  - 9.6.5.4. Saudi Arabia: Hemostasis and Tissue Sealing Agents Market, by End User, 2020-2034 (USD Billion)
- 9.6.6. Hemostasis and Tissue Sealing Agents Market - UAE
  - 9.6.6.1. UAE: Hemostasis and Tissue Sealing Agents Market, by Product, 2020-2034 (USD Billion)
  - 9.6.6.2. UAE: Hemostasis and Tissue Sealing Agents Market, by Material, 2020-2034 (USD Billion)
  - 9.6.6.3. UAE: Hemostasis and Tissue Sealing Agents Market, by Application, 2020-2034 (USD Billion)
  - 9.6.6.4. UAE: Hemostasis and Tissue Sealing Agents Market, by End User, 2020-2034 (USD Billion)
- 9.6.7. Hemostasis and Tissue Sealing Agents Market - Israel
  - 9.6.7.1. Israel: Hemostasis and Tissue Sealing Agents Market, by Product, 2020-2034 (USD Billion)
  - 9.6.7.2. Israel: Hemostasis and Tissue Sealing Agents Market, by Material, 2020-2034 (USD Billion)
  - 9.6.7.3. Israel: Hemostasis and Tissue Sealing Agents Market, by Application, 2020-2034 (USD Billion)
  - 9.6.7.4. Israel: Hemostasis and Tissue Sealing Agents Market, by End User, 2020-2034 (USD Billion)
- 9.6.8. Hemostasis and Tissue Sealing Agents Market - South Africa
  - 9.6.8.1. South Africa: Hemostasis and Tissue Sealing Agents Market, by Product, 2020-2034 (USD Billion)
  - 9.6.8.2. South Africa: Hemostasis and Tissue Sealing Agents Market, by Material, 2020-2034 (USD Billion)
  - 9.6.8.3. South Africa: Hemostasis and Tissue Sealing Agents Market, by Application, 2020-2034 (USD Billion)
  - 9.6.8.4. South Africa: Hemostasis and Tissue Sealing Agents Market, by End User, 2020-2034 (USD Billion)
- 9.6.9. Hemostasis and Tissue Sealing Agents Market - Rest of Middle East & Africa
  - 9.6.9.1. Rest of Middle East & Africa: Hemostasis and Tissue Sealing Agents Market, by Product, 2020-2034 (USD Billion)
  - 9.6.9.2. Rest of Middle East & Africa: Hemostasis and Tissue Sealing Agents Market, by Material, 2020-2034 (USD Billion)
  - 9.6.9.3. Rest of Middle East & Africa: Hemostasis and Tissue Sealing Agents Market, by Application, 2020-2034 (USD Billion)
  - 9.6.9.4. Rest of Middle East & Africa: Hemostasis and Tissue Sealing Agents Market, by End User, 2020-2034 (USD Billion)
9.7. Hemostasis and Tissue Sealing Agents Market - Latin America
- 9.7.1. Latin America: Hemostasis and Tissue Sealing Agents Market, by Product, 2020-2034 (USD Billion)
- 9.7.2. Latin America: Hemostasis and Tissue Sealing Agents Market, by Material, 2020-2034 (USD Billion)
- 9.7.3. Latin America: Hemostasis and Tissue Sealing Agents Market, by Application, 2020-2034 (USD Billion)
- 9.7.4. Latin America: Hemostasis and Tissue Sealing Agents Market, by End User, 2020-2034 (USD Billion)
- 9.7.5. Hemostasis and Tissue Sealing Agents Market - Mexico
  - 9.7.5.1. Mexico: Hemostasis and Tissue Sealing Agents Market, by Product, 2020-2034 (USD Billion)
  - 9.7.5.2. Mexico: Hemostasis and Tissue Sealing Agents Market, by Material, 2020-2034 (USD Billion)
  - 9.7.5.3. Mexico: Hemostasis and Tissue Sealing Agents Market, by Application, 2020-2034 (USD Billion)
  - 9.7.5.4. Mexico: Hemostasis and Tissue Sealing Agents Market, by End User, 2020-2034 (USD Billion)
- 9.7.6. Hemostasis and Tissue Sealing Agents Market - Brazil
  - 9.7.6.1. Brazil: Hemostasis and Tissue Sealing Agents Market, by Product, 2020-2034 (USD Billion)
  - 9.7.6.2. Brazil: Hemostasis and Tissue Sealing Agents Market, by Material, 2020-2034 (USD Billion)
  - 9.7.6.3. Brazil: Hemostasis and Tissue Sealing Agents Market, by Application, 2020-2034 (USD Billion)
  - 9.7.6.4. Brazil: Hemostasis and Tissue Sealing Agents Market, by End User, 2020-2034 (USD Billion)
- 9.7.7. Hemostasis and Tissue Sealing Agents Market - Argentina
  - 9.7.7.1. Argentina: Hemostasis and Tissue Sealing Agents Market, by Product, 2020-2034 (USD Billion)
  - 9.7.7.2. Argentina: Hemostasis and Tissue Sealing Agents Market, by Material, 2020-2034 (USD Billion)
  - 9.7.7.3. Argentina: Hemostasis and Tissue Sealing Agents Market, by Application, 2020-2034 (USD Billion)
  - 9.7.7.4. Argentina: Hemostasis and Tissue Sealing Agents Market, by End User, 2020-2034 (USD Billion)
- 9.7.8. Hemostasis and Tissue Sealing Agents Market - Rest of Latin America
  - 9.7.8.1. Rest of Latin America: Hemostasis and Tissue Sealing Agents Market, by Product, 2020-2034 (USD Billion)
  - 9.7.8.2. Rest of Latin America: Hemostasis and Tissue Sealing Agents Market, by Material, 2020-2034 (USD Billion)
  - 9.7.8.3. Rest of Latin America: Hemostasis and Tissue Sealing Agents Market, by Application, 2020-2034 (USD Billion)
  - 9.7.8.4. Rest of Latin America: Hemostasis and Tissue Sealing Agents Market, by End User, 2020-2034 (USD Billion)

10. Competitive Landscape

10.1. Expansion and Acquisition Analysis
- 10.1.1. Expansion
- 10.1.2. Acquisitions
10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

11.1. Baxter International
- 11.1.1. Company Overview
- 11.1.2. Financial Performance
- 11.1.3. Product Benchmarking
- 11.1.4. Recent Development
11.2. Ethicon (a Subsidiary of Johnson & Johnson)
- 11.2.1. Company Overview
- 11.2.2. Financial Performance
- 11.2.3. Product Benchmarking
- 11.2.4. Recent Development
11.3. B. Braun
- 11.3.1. Company Overview
- 11.3.2. Financial Performance
- 11.3.3. Product Benchmarking
- 11.3.4. Recent Development
11.4. Integra LifeSciences
- 11.4.1. Company Overview
- 11.4.2. Financial Performance
- 11.4.3. Product Benchmarking
- 11.4.4. Recent Development
11.5. Medtronic
- 11.5.1. Company Overview
- 11.5.2. Financial Performance
- 11.5.3. Product Benchmarking
- 11.5.4. Recent Development
11.6. CryoLife
- 11.6.1. Company Overview
- 11.6.2. Financial Performance
- 11.6.3. Product Benchmarking
- 11.6.4. Recent Development
11.7. CSL Behring
- 11.7.1. Company Overview
- 11.7.2. Financial Performance
- 11.7.3. Product Benchmarking
- 11.7.4. Recent Development
11.8. Stryker Corporation
- 11.8.1. Company Overview
- 11.8.2. Financial Performance
- 11.8.3. Product Benchmarking
- 11.8.4. Recent Development
11.9. Pfizer
- 11.9.1. Company Overview
- 11.9.2. Financial Performance
- 11.9.3. Product Benchmarking
- 11.9.4. Recent Development
11.10. Cohera Medical
- 11.10.1. Company Overview
- 11.10.2. Financial Performance
- 11.10.3. Product Benchmarking
- 11.10.4. Recent Development
11.11. Advanced Medical Solutions Group
- 11.11.1. Company Overview
- 11.11.2. Financial Performance
- 11.11.3. Product Benchmarking
- 11.11.4. Recent Development
11.12. Haemacure Corporation
- 11.12.1. Company Overview
- 11.12.2. Financial Performance
- 11.12.3. Product Benchmarking
- 11.12.4. Recent Development
11.13. Mallinckrodt Pharmaceuticals
- 11.13.1. Company Overview
- 11.13.2. Financial Performance
- 11.13.3. Product Benchmarking
- 11.13.4. Recent Development
11.14. Arch Therapeutics
- 11.14.1. Company Overview
- 11.14.2. Financial Performance
- 11.14.3. Product Benchmarking
- 11.14.4. Recent Development